Molecular Monitoring And Tailored Strategy With Pre-Emptive Rituximab Treatment For Molecular Relapse; Results From The Nordic Mantle Cell Lymphoma Studies (Mcl2 And Mcl3) With Median Follow-Up Of 8.5 Years
BLOOD（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要